Eagle Asset Management Inc. Invests $3.25 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Eagle Asset Management Inc. bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 37,829 shares of the company's stock, valued at approximately $3,251,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Pathway Financial Advisers LLC purchased a new stake in GE HealthCare Technologies in the first quarter worth approximately $25,000. LGT Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares during the period. Fred Alger Management LLC purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter worth $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,000. Finally, Ashton Thomas Securities LLC purchased a new stake in GE HealthCare Technologies during the third quarter valued at $26,000. Institutional investors own 82.06% of the company's stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.27% of the company's stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC traded down $0.15 during mid-day trading on Tuesday, reaching $82.51. The company's stock had a trading volume of 2,040,472 shares, compared to its average volume of 3,084,686. The stock has a fifty day moving average of $88.27 and a two-hundred day moving average of $83.62. The firm has a market capitalization of $37.70 billion, a PE ratio of 22.67, a P/E/G ratio of 2.95 and a beta of 1.24. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm's revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.99 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's payout ratio is currently 3.30%.

Analyst Ratings Changes

GEHC has been the subject of a number of recent research reports. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Evercore ISI upped their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $94.36.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.